High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 TrialChristophe Massard, Jean‐Charles Soria, Maud Ngo‐Camus et al.|Cancer Discovery|2017Cited by 781
Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical TrialsMaria Schwaederlé, Razelle Kurzrock, Melissa Zhao et al.|Journal of Clinical Oncology|2015Cited by 497
Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical OutcomeVéronique Winnepenninckx, Alan Spatz, Vladimir Lazar et al.|JNCI Journal of the National Cancer Institute|2006Cited by 480
Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trialJordi Rodón, Razelle Kurzrock, Jean‐Charles Soria et al.|Annals of Oncology|2015Cited by 75
Is ulceration in cutaneous melanoma just a prognostic and predictive factor or is ulcerated melanoma a distinct biologic entity?Alexander M.M. Eggermont, Caroline Robert, Alan Spatz et al.|Current Opinion in Oncology|2012Cited by 48